1. Home
  2. ADAP vs GSIT Comparison

ADAP vs GSIT Comparison

Compare ADAP & GSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAP
  • GSIT
  • Stock Information
  • Founded
  • ADAP 2008
  • GSIT 1995
  • Country
  • ADAP United Kingdom
  • GSIT United States
  • Employees
  • ADAP N/A
  • GSIT N/A
  • Industry
  • ADAP Biotechnology: Pharmaceutical Preparations
  • GSIT Semiconductors
  • Sector
  • ADAP Health Care
  • GSIT Technology
  • Exchange
  • ADAP Nasdaq
  • GSIT Nasdaq
  • Market Cap
  • ADAP 71.6M
  • GSIT 62.9M
  • IPO Year
  • ADAP 2015
  • GSIT N/A
  • Fundamental
  • Price
  • ADAP $0.21
  • GSIT $2.14
  • Analyst Decision
  • ADAP Strong Buy
  • GSIT
  • Analyst Count
  • ADAP 5
  • GSIT 0
  • Target Price
  • ADAP $1.93
  • GSIT N/A
  • AVG Volume (30 Days)
  • ADAP 2.4M
  • GSIT 134.8K
  • Earning Date
  • ADAP 03-20-2025
  • GSIT 05-01-2025
  • Dividend Yield
  • ADAP N/A
  • GSIT N/A
  • EPS Growth
  • ADAP N/A
  • GSIT N/A
  • EPS
  • ADAP N/A
  • GSIT N/A
  • Revenue
  • ADAP $178,032,000.00
  • GSIT $19,787,000.00
  • Revenue This Year
  • ADAP N/A
  • GSIT N/A
  • Revenue Next Year
  • ADAP $56.87
  • GSIT N/A
  • P/E Ratio
  • ADAP N/A
  • GSIT N/A
  • Revenue Growth
  • ADAP 195.34
  • GSIT N/A
  • 52 Week Low
  • ADAP $0.20
  • GSIT $2.01
  • 52 Week High
  • ADAP $1.55
  • GSIT $6.02
  • Technical
  • Relative Strength Index (RSI)
  • ADAP 14.09
  • GSIT 32.02
  • Support Level
  • ADAP $0.26
  • GSIT $2.55
  • Resistance Level
  • ADAP $0.47
  • GSIT $2.54
  • Average True Range (ATR)
  • ADAP 0.04
  • GSIT 0.13
  • MACD
  • ADAP -0.02
  • GSIT -0.02
  • Stochastic Oscillator
  • ADAP 1.23
  • GSIT 15.07

About ADAP Adaptimmune Therapeutics plc

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

Share on Social Networks: